The Los Angeles Post
U.S. World Business Lifestyle
Today: March 31, 2025
Today: March 31, 2025
David  Carnevali

David Carnevali

Staff Writer

Latest From David Carnevali

Business|Economy|Finance

Exclusive-Carlyle in exclusive talks for $7 billion-plus Medtronic units deal-sources

Private equity firm Carlyle Group Inc has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc at a

Exclusive-Carlyle in exclusive talks for $7 billion-plus Medtronic units deal-sources
Business|Finance

Top Citigroup industrials banker to join Jefferies -sources

Investment bank and capital markets firm Jefferies has hired industrial banker Francis Tucci from Citigroup for a senior role, according

Top Citigroup industrials banker to join Jefferies -sources
Business|Finance|Health|US

Cigna explores shedding Medicare Advantage business -sources

U.S. health insurer Cigna Group is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older

Cigna explores shedding Medicare Advantage business -sources
Business|Finance

Exclusive-Jacobs poised to merge government consulting unit with Amentum

Engineering consultant Jacobs Solutions Inc is in advanced talks to merge its government consulting arm at a valuation of more than $4 billion with private equity-owned

Exclusive-Jacobs poised to merge government consulting unit with Amentum
Business|Finance

Blackstone explores sale of Anthos Therapeutics -sources

Private equity firm Blackstone Inc is exploring the sale of Anthos Therapeutics, a developer of a new generation of blood thinners it launched four years ago

Blackstone explores sale of Anthos Therapeutics -sources
Business|Finance|Health

Exclusive-AbbVie nears roughly $8 billion deal for drug developer Cerevel-sources

AbbVie Inc is nearing an approximately $8 billion deal to acquire Cerevel Therapeutics Holdings Inc, a developer of drugs for neurological conditions such as

Exclusive-AbbVie nears roughly $8 billion deal for drug developer Cerevel-sources
Business|Finance|Health

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

Healthcare dealmakers are making their way to San Francisco for a major industry

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Business|Finance|US

Exclusive-Icahn drops Illumina board challenge threat, sources say

Activist investor Carl Icahn has dropped a threat to mount a new challenge to Illumina's board, sparing the U.S. gene sequencing company

Exclusive-Icahn drops Illumina board challenge threat, sources say
Business|Finance

Platinum Equity explores $2 billion-plus Club Car sale, sources say

Private equity firm Platinum Equity has hired advisers to explore a sale of Club Car that could value the golf cart maker at more than $2 billion,

Platinum Equity explores $2 billion-plus Club Car sale, sources say
Business|Economy|Finance

Exclusive-Boeing mulls shedding Airbus work in potential Spirit Aero deal

Boeing is looking at how Spirit AeroSystems could shed or sharply reduce its ties to Airbus, as the supply-chain giant's work for the

Exclusive-Boeing mulls shedding Airbus work in potential Spirit Aero deal

Follow